Beam Therapeutics Inc. (BMV:BEAM)
604.00
+119.00 (24.54%)
At close: Jan 13, 2026
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of 46.27 billion as of February 10, 2026. Its market cap has increased by 10.67% in one year.
Market Cap
46.27B
Enterprise Value
30.40B
Revenue
1.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
604.00
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from 6.12B to 46.27B, an increase of 655.70%. That is a compound annual growth rate of 39.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 46.27B | -6.06% |
| Dec 31, 2025 | 49.25B | 19.75% |
| Dec 31, 2024 | 41.13B | 12.67% |
| Dec 29, 2023 | 36.50B | -30.47% |
| Dec 30, 2022 | 52.50B | -51.93% |
| Dec 31, 2021 | 109.21B | 19.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GCC, S.A.B. de C.V. | 65.43B |
| Fideicomiso Irrevocable No. F/3277 en Banco Invex, S. A. Institución de Banca Múltiple, INVEX Grupo | 60.16B |
| Grupo Aeroméxico | 48.02B |
| Corporación Inmobiliaria Vesta | 44.67B |
| Alsea | 43.78B |
| Fibra Danhos | 42.65B |
| Orbia Advance Corporation | 39.69B |
| Grupo Profuturo | 35.29B |